Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 33 entries
View as:

Comparative Efficacy and Safety of Fenoverine

Phase: N/A Priority: Normal
NCT ID: NCT01507922 Org: User:
Start: 12/31/11 End: 06/30/13 Due: 06/30/14

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT00558493 Org: User:
Start: 11/30/07 End: - Due: -

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01264133 Org: User:
Start: 09/30/09 End: 12/31/14 Due: 12/31/15

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01258699 Org: User:
Start: 08/31/09 End: - Due: -

A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01581242 Org: User:
Start: 04/30/12 End: - Due: -

A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00641082 Org: User:
Start: 02/29/08 End: - Due: -

A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03465787 Org: User:
Start: 04/09/18 End: 10/26/22 Due: 10/26/23

A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

Phase: N/A Priority: Normal
NCT ID: NCT01264094 Org: User:
Start: 11/30/09 End: 06/30/15 Due: 06/30/16

An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine

Phase: N/A Priority: Normal
NCT ID: NCT01264107 Org: User:
Start: 04/30/09 End: 04/30/12 Due: 04/30/13

Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201

Phase: N/A Priority: Normal
NCT ID: NCT00362700 Org: User:
Start: 07/31/03 End: 10/31/05 Due: 10/31/06

Long-term Study With Clevudine

Phase: N/A Priority: Normal
NCT ID: NCT00558818 Org: User:
Start: 06/30/07 End: 09/30/11 Due: 09/30/12

A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B

Phase: N/A Priority: Normal
NCT ID: NCT00672867 Org: User:
Start: 12/31/07 End: 09/30/14 Due: 09/30/15

Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

Phase: N/A Priority: Normal
NCT ID: NCT00362674 Org: User:
Start: 06/30/05 End: - Due: -

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV

Phase: N/A Priority: Normal
NCT ID: NCT00313274 Org: User:
Start: 07/31/03 End: 12/31/04 Due: 12/31/05

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

Phase: N/A Priority: Normal
NCT ID: NCT04377945 Org: User:
Start: 04/28/21 End: 02/14/24 Due: 02/14/25

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01261143 Org: User:
Start: 08/31/10 End: - Due: -

A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02711969 Org: User:
Start: 03/31/16 End: 03/31/19 Due: 03/31/20

A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

Phase: N/A Priority: Normal
NCT ID: NCT01266005 Org: User:
Start: 08/31/09 End: 01/31/14 Due: 01/31/15

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC

Phase: N/A Priority: Normal
NCT ID: NCT01263002 Org: User:
Start: 06/30/10 End: 09/30/13 Due: 09/30/14

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01258686 Org: User:
Start: 11/30/10 End: 08/31/13 Due: 08/31/14

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV

Phase: N/A Priority: Normal
NCT ID: NCT00313287 Org: User:
Start: 06/30/03 End: 11/30/04 Due: 11/30/05

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Phase: N/A Priority: Normal
NCT ID: NCT02439203 Org: User:
Start: 05/31/15 End: 01/31/16 Due: 01/31/17

Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT01624779 Org: User:
Start: 04/30/12 End: 05/31/14 Due: 05/31/15

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06014853 Org: User:
Start: 08/10/23 End: 11/16/23 Due: 11/16/24

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Phase: N/A Priority: Normal
NCT ID: NCT01264367 Org: User:
Start: 12/31/08 End: 05/31/14 Due: 05/31/15